7.470USD-1.19%Mkt Cap: 274.23M USDP/E: —Last update: 2026-06-11
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its produc…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap274.23M USD
Enterprise Value645.95M USD
Revenue (TTM)5.20M USD
Gross Profit-10.52M USD
Net Income (TTM)-173.80M USD
Revenue/Share0.1430 USD
Last Price7.470 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees61
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS04216R1023
Valuation
P/E (Trailing)—
P/E (Forward)-3.89
PEG—
EV/EBITDA-21.39
EV/Revenue124.17
P/S52.72
P/B-0.88
EPS (TTM)-7.78
EPS (Forward)-1.57
52W Range
1.74039% of range16.34
52W High16.34 USD
52W Low1.740 USD
Profitability
Gross Margin-202.13%
Oper. Margin-1113.44%
EBITDA Margin0.00%
Profit Margin0.00%
ROE79.51%
ROA-226.06%
Growth
Revenue Growth60.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.76M USD
CapEx (TTM)542.00K USD
FCF Margin-502.48%
FCF Yield-9.53%
Net Debt368.92M USD
Net Debt/EBITDA-12.21
Balance Sheet
Debt/Equity-1.32
Current Ratio0.64
Quick Ratio0.52
Book Value/Sh-8.5030 USD
Cash/Share0.1300 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMay 10, 2019
Splits
Last Split1:14
Split DateMay 10, 2019
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)17.50 USD
Target Range15.00 USD – 20.00 USD
# Analysts2
Ownership
Shares Out.36.71M
Float11.32M
Insiders68.53%
Institutions10.46%
Short Interest
Short Ratio2.6d
Short % Float1.94%
Short % Out.0.57%
Shares Short209.36K
Short (prev mo.)230.02K
Technical
SMA 509.756 (-23.4%)
SMA 2007.082 (+5.5%)
Beta—
S&P 52W Chg20.21%
Avg Vol (30d)70.15K
Avg Vol (10d)63.43K
Technical Indicators
RSI (14)38.5
MACD-0.5222
MACD Signal-0.5681
MACD Hist.+0.0459
BB Upper8.535 USD
BB Middle7.923 USD
BB Lower7.312 USD
BB Width15.44%
ATR (14)0.8700 USD
Vol Ratio (20d)0.98x